Aug. 4 –- Kannalife Sciences Founder Thoma Kikis and Leafly CEO Brendan Kennedy discuss using cannabinoid–based therapeutics to treat chronic traumatic encephalopathy and Leafly’s New York Times marijuana ad. They speak on “Street Smart.” (Source: Bloomberg)
